A few milligrams of melatonin make up a small fraction of a gummy. That leaves most of the piece to carry the flavour and texture, while the ingredient still needs to be distributed consistently. A batch average can describe something different from individual-piece variation. The finished assay, the sampling method and observations during storage each add a different part of the product’s quality picture.

The 2023 gummy testing
A 2023 JAMA research letter assessed 25 US melatonin gummy products. Twenty-two were outside its 10% label-accuracy criterion; measured content among products with detected melatonin ranged from 74% to 347% of the labelled amount. This selected sample does not describe every product now on sale. The findings also do not identify the manufacturing cause for each discrepancy.
Low loading and batch consistency
A hypothetical 3 mg addition in a 3 g piece is 0.1% by mass. Premixing, blending and sampling can therefore matter even when the piece looks uniform. The agreed specification can distinguish the batch result from any assessment of piece-to-piece variation. Such a specification is more precise than promising that every piece will return an identical laboratory number.
Light, moisture, formulation and processing conditions can affect a stability assessment. Data from forced degradation of a pure ingredient does not directly predict loss in a packaged gummy. The relevant study uses the intended formula and pack, with storage conditions and time points recorded. A particular accelerated protocol is not a universal requirement for all gummy products.
The intended market
Melatonin is not handled in the same way everywhere. US products may be marketed as dietary supplements under the applicable framework. In the UK, the NHS describes melatonin as a prescription medicine. A familiar product seen on a US shelf therefore does not establish the route for a UK launch. The destination and proposed presentation belong in the development brief from the outset.
The production discussion
Gummy development forms part of our OEM and ODM work. For a proposed melatonin project, the destination, serving weight and analytical specification can be brought into the same brief. The gummy range provides the format background for that discussion.
FAQ
Does the study show that all melatonin gummies are inaccurate?
No. It reports results for the products sampled and the criterion used in that study. A current product needs its own batch and stability evidence.
Can changing gelatin to pectin leave everything else unchanged?
A different gel can affect processing, texture and storage behaviour. Its suitability is assessed with the formula and the intended specification, rather than as an isolated ingredient substitution.
Final Thoughts
A small declared amount can involve quite detailed manufacturing and analytical work. The product is easier to describe when the serving, sampling plan and storage evidence refer to the same formula. Published market testing gives useful context, while the specification and records for the actual batch provide the information relevant to the product being supplied.
Ding Shaohua, Foreign Trade Manager, takes the enquiries that arrive this way. The same person answers on WhatsApp, TikTok, LinkedIn and Facebook, and the sample questions usually arrive by WhatsApp first.
All News